Sara Sannino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sara Sannino has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Jeffrey L. Brodsky
Department of Biological Sciences, University of Pittsburgh, Pittsburgh, USA
24 shared publications - Allison M. Manuel
University of South Carolina, USA
19 shared publications - Chaowei Shang
Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania
19 shared publications - Peter Wipf
University of Pittsburgh
19 shared publications - Stacy Gelhaus Wendell
University of Pittsburgh
19 shared publications - Roberto Sitia
Vita-Salute San Raffaele University and Consiglio Nazionale delle Ricerche, Institute of Agricultural Biology and Biotechnology, Milan, Italy
3 shared publications
Latest Publications
- 13 March 2026
- Published by Elsevier in Cancer Letters
- Vol. 646, 218435
Identification of the MRTFA/SRF pathway as a critical regulator of quiescence and chemotherapy resistance in cancer
- 13 March 2026
- Published by Elsevier in Cancer Letters
- Vol. 646, 218435
Identification of the MRTFA/SRF pathway as a critical regulator of quiescence and chemotherapy resistance in cancer
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure Legend 1 and Supplementary Table 1 from Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress
Legend to supplementary figure S1 and Table S1 containing a list of reagents and chemicals used to perform the experiments in the manuscript
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure Legend 1 and Supplementary Table 1 from Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress
Legend to supplementary figure S1 and Table S1 containing a list of reagents and chemicals used to perform the experiments in the manuscript
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress
S1. Amino acid modulation orchestrates apoptosis when proteostasis is compromised.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress
S1. Amino acid modulation orchestrates apoptosis when proteostasis is compromised.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress
Protein homeostasis (proteostasis) regulates tumor growth and proliferation when cells are exposed to proteotoxic stress, such as during treatment with certain chemotherapeutics. Consequently, cancer cells depend to a greater extent on stress signaling, and require the integrated stress response (ISR), amino acid metabolism, and efficient protein folding and degradation pathways to survive. To define how these interconnected pathways are wired when cancer cells are challenged with proteotoxic stress, we investigated how amino acid abundance influences cell survival when Hsp70, a master proteostasis regulator, is inhibited. We previously demonstrated that cancer cells exposed to a specific Hsp70 inhibitor induce the ISR via the action of two sensors, GCN2 and PERK, in stress-resistant and sensitive cells, respectively. In resistant cells, the induction of GCN2 and autophagy supported resistant cell survival, yet the mechanism by which these events were induced remained unclear. We now report that amino acid availability reconfigures the proteostasis network. Amino acid supplementation, and in particular arginine addition, triggered cancer cell death by blocking autophagy. Consistent with the importance of amino acid availability, which when limited activates GCN2, resistant cancer cells succumbed when challenged with a potentiator for another amino acid sensor, mTORC1, in conjunction with Hsp70 inhibition.Implications:These data position amino acid abundance, GCN2, mTORC1, and autophagy as integrated therapeutic targets whose coordinated modulation regulates the survival of proteotoxic-resistant breast cancer cells.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress
Protein homeostasis (proteostasis) regulates tumor growth and proliferation when cells are exposed to proteotoxic stress, such as during treatment with certain chemotherapeutics. Consequently, cancer cells depend to a greater extent on stress signaling, and require the integrated stress response (ISR), amino acid metabolism, and efficient protein folding and degradation pathways to survive. To define how these interconnected pathways are wired when cancer cells are challenged with proteotoxic stress, we investigated how amino acid abundance influences cell survival when Hsp70, a master proteostasis regulator, is inhibited. We previously demonstrated that cancer cells exposed to a specific Hsp70 inhibitor induce the ISR via the action of two sensors, GCN2 and PERK, in stress-resistant and sensitive cells, respectively. In resistant cells, the induction of GCN2 and autophagy supported resistant cell survival, yet the mechanism by which these events were induced remained unclear. We now report that amino acid availability reconfigures the proteostasis network. Amino acid supplementation, and in particular arginine addition, triggered cancer cell death by blocking autophagy. Consistent with the importance of amino acid availability, which when limited activates GCN2, resistant cancer cells succumbed when challenged with a potentiator for another amino acid sensor, mTORC1, in conjunction with Hsp70 inhibition.Implications:These data position amino acid abundance, GCN2, mTORC1, and autophagy as integrated therapeutic targets whose coordinated modulation regulates the survival of proteotoxic-resistant breast cancer cells.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
S1. Amino acid modulation orchestrates apoptosis when proteostasis is compromised.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
S1. Amino acid modulation orchestrates apoptosis when proteostasis is compromised.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
S1. Amino acid modulation orchestrates apoptosis when proteostasis is compromised.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
S1. Amino acid modulation orchestrates apoptosis when proteostasis is compromised.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure Legend 1 and Supplementary Table 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
Legend to supplementary figure S1 and Table S1 containing a list of reagents and chemicals used to perform the experiments in the manuscript
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure Legend 1 and Supplementary Table 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
Legend to supplementary figure S1 and Table S1 containing a list of reagents and chemicals used to perform the experiments in the manuscript
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure Legend 1 and Supplementary Table 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
Legend to supplementary figure S1 and Table S1 containing a list of reagents and chemicals used to perform the experiments in the manuscript
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure Legend 1 and Supplementary Table 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
Legend to supplementary figure S1 and Table S1 containing a list of reagents and chemicals used to perform the experiments in the manuscript
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Data from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
Protein homeostasis (proteostasis) regulates tumor growth and proliferation when cells are exposed to proteotoxic stress, such as during treatment with certain chemotherapeutics. Consequently, cancer cells depend to a greater extent on stress signaling, and require the integrated stress response (ISR), amino acid metabolism, and efficient protein folding and degradation pathways to survive. To define how these interconnected pathways are wired when cancer cells are challenged with proteotoxic stress, we investigated how amino acid abundance influences cell survival when Hsp70, a master proteostasis regulator, is inhibited. We previously demonstrated that cancer cells exposed to a specific Hsp70 inhibitor induce the ISR via the action of two sensors, GCN2 and PERK, in stress-resistant and sensitive cells, respectively. In resistant cells, the induction of GCN2 and autophagy supported resistant cell survival, yet the mechanism by which these events were induced remained unclear. We now report that amino acid availability reconfigures the proteostasis network. Amino acid supplementation, and in particular arginine addition, triggered cancer cell death by blocking autophagy. Consistent with the importance of amino acid availability, which when limited activates GCN2, resistant cancer cells succumbed when challenged with a potentiator for another amino acid sensor, mTORC1, in conjunction with Hsp70 inhibition. Implications: These data position amino acid abundance, GCN2, mTORC1, and autophagy as integrated therapeutic targets whose coordinated modulation regulates the survival of proteotoxic-resistant breast cancer cells.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
Protein homeostasis (proteostasis) regulates tumor growth and proliferation when cells are exposed to proteotoxic stress, such as during treatment with certain chemotherapeutics. Consequently, cancer cells depend to a greater extent on stress signaling, and require the integrated stress response (ISR), amino acid metabolism, and efficient protein folding and degradation pathways to survive. To define how these interconnected pathways are wired when cancer cells are challenged with proteotoxic stress, we investigated how amino acid abundance influences cell survival when Hsp70, a master proteostasis regulator, is inhibited. We previously demonstrated that cancer cells exposed to a specific Hsp70 inhibitor induce the ISR via the action of two sensors, GCN2 and PERK, in stress-resistant and sensitive cells, respectively. In resistant cells, the induction of GCN2 and autophagy supported resistant cell survival, yet the mechanism by which these events were induced remained unclear. We now report that amino acid availability reconfigures the proteostasis network. Amino acid supplementation, and in particular arginine addition, triggered cancer cell death by blocking autophagy. Consistent with the importance of amino acid availability, which when limited activates GCN2, resistant cancer cells succumbed when challenged with a potentiator for another amino acid sensor, mTORC1, in conjunction with Hsp70 inhibition. Implications: These data position amino acid abundance, GCN2, mTORC1, and autophagy as integrated therapeutic targets whose coordinated modulation regulates the survival of proteotoxic-resistant breast cancer cells.
- Open Access
- 5 July 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress
S1. Amino acid modulation orchestrates apoptosis when proteostasis is compromised.
- 5 July 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress
S1. Amino acid modulation orchestrates apoptosis when proteostasis is compromised.